Maquet beats Boston and St Jude to US LAA market
This article was originally published in Clinica
Maquet Cardiovascular has gained a foothold in the left atrial appendage (LAA) closure market, viewed by key heart device makers as a growth area, with the acquisition of LAAx.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.